EW | Edwards Lifesciences Corporation Stock Overview

(Stock Exchange: NYSE)

Day's Range	69.97 - 71.00
52 Week Range	58.93 - 96.12
Beta	1.10
Implied Volatility	35.54%
IV Rank	40.63%
Day's Volume	2,083,880
Average Volume	6,077,509
Shares Outstanding	589,800,000
Market Cap	41,569,104,000
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2000-03-27

Valuation
Profitability
Growth
Health
P/E Ratio	27.21
Forward P/E Ratio	47.62
EPS	2.59
1YR Price Target	131.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	19,800
Country	USA
Website	EW

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery.

EW's peers: ALGN, BSX, DXCM, MDT, ABT, ZBH, SYK, PODD, TNDM, INMD, MASS, NNOX, PHG, SENS

*Chart delayed

Analyzing fundamentals for EW we got that it has strong fundamentals where Valuation is considered to be slightly undervalued, Profitability is stunning wealthy, Growth is very good and Health is confidently strong. For more detailed analysis please see EW Fundamentals page.

Watching at EW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on EW Technicals page.